MeiraGTx Holdings Plc (MGTX)
7.98
-0.16
(-1.97%)
USD |
NASDAQ |
Nov 20, 16:00
7.99
+0.01
(+0.13%)
After-Hours: 20:00
MeiraGTx Holdings Research and Development Expense (TTM) : 159.94M for Sept. 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 159.94M |
| June 30, 2026 | 153.16M |
| March 31, 2026 | 128.82M |
| December 31, 2025 | 129.62M |
| September 30, 2025 | 122.49M |
| June 30, 2025 | 116.20M |
| March 31, 2025 | 117.64M |
| December 31, 2024 | 119.18M |
| September 30, 2024 | 129.17M |
| June 30, 2024 | 130.78M |
| March 31, 2024 | 115.78M |
| December 31, 2023 | 103.78M |
| September 30, 2023 | 86.98M |
| June 30, 2023 | 83.12M |
| March 31, 2023 | 86.28M |
| September 30, 2022 | 77.58M |
| June 30, 2022 | 82.33M |
| Date | Value |
|---|---|
| March 31, 2022 | 73.52M |
| December 31, 2021 | 67.13M |
| September 30, 2021 | 58.51M |
| June 30, 2021 | 41.52M |
| March 31, 2021 | 42.54M |
| December 31, 2020 | 33.91M |
| September 30, 2020 | 26.42M |
| June 30, 2020 | 26.41M |
| March 31, 2020 | 19.98M |
| December 31, 2019 | 24.88M |
| September 30, 2019 | 38.16M |
| June 30, 2019 | 41.65M |
| March 31, 2019 | 39.67M |
| December 31, 2018 | 33.62M |
| September 30, 2018 | 29.22M |
| June 30, 2018 | 26.47M |
| March 31, 2018 | 23.50M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Xencor, Inc. | 285.70M |
| UroGen Pharma Ltd. | 73.21M |
| Ironwood Pharmaceuticals, Inc. | 92.76M |
| Viking Therapeutics, Inc. | 586.17M |
| IDEAYA Biosciences, Inc. | 412.59M |